EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Smartphone-Based Physical Activity Program to Reduce “Chemo-Brain” Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial

Zachary C Pope iD, Andriy Yabluchanskiy iD, Peter Mukli iD, Michael C Robertson iD, Jason A Oliver iD, Sarah J Borengasser iD, Meghan M Ratke iD, Jacob E Matney iD, Chris Mixon iD, Christina Henson iD, J Mikhail Kellawan iD

JMIR Research Protocols · 2025

DOI: 10.2196/79739 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Zachary C Pope und 10 weiteren Autor:innen. Beteiligte Einrichtung: TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cancer Survivors, Exercise, Smartphone. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The US cancer survivor population is projected to hit 26M by 2040. Chemotherapy is an effective cancer treatment, but can diminish cancer survivors’ quality of life—particularly cognitive function—through select pathophysiological processes, including immune system and antioxidant dysregulation. The resulting cytokine release can impair cerebrovascular function—likely contributing to chemotherapy-induced cognitive impairment (CICI; “chemo-brain”). Type 2 diabetes mellitus (T2DM)—a common cancer survivor comorbidity—shares underlying pathophysiology with CICI. Cancer survivors with T2DM might thus have a higher CICI risk than those without T2DM. Physical activity (PA) counteracts CICI’s and T2DM’s pathophysiology, but little to no research has been conducted assessing the impact of PA on this joint pathophysiology.

Objective

To compare cerebrovascular and cognitive function as well as proinflammatory, cardiometabolic, epigenetic, and psychosocial outcomes between ancer survivors with and without T2DM pre- to postengagement in a 12-week technology-based PA program grounded in the Social Cognitive Theory. We hypothesize that cancer survivors with and without T2DM will demonstrate similar pre to poststudy improvements in psychosocial outcomes, but that changes in cerebrovascular and cardiometabolic outcomes, as well as PA engagement, will be greater for cancer survivors with T2DM. We also believe that each group will have distinct epigenetic profiles that will change pre to poststudy.

Methods

We are conducting a 30-participant pilot study in cancer survivors with (n=15) and without (n=15) T2DM—all of whom report currently experiencing “chemo-brain.” To account for attrition, we are recruiting 38 cancer survivors from Oklahoma City, OK, and the surrounding area. Among the most important eligibility criteria are the self-report of cognitive difficulties following primary cancer treatment, being ≥18 years old, being within 3 years of primary cancer treatment, and not meeting nationally recommended PA guidelines. Participants receive 2 smartphone apps. One smartphone app provides health education and the ability to set goals and journal about their wellness journey. The other provides a workout program continually tailored to each participant via their communication with the study exercise physiologist, with resistance bands and a wearable device provided to support the program. At Baseline and Poststudy, we assess cerebrovascular function (transcranial doppler [TCD]), cognition (National Institutes of Health Toolbox), cardiometabolic outcomes (venipuncture), and epigenetics (saliva collection). Participants also wear accelerometers at Baseline and Poststudy to objectively assess PA, with Baseline, Midpoint, and Poststudy surveys assessing psychosocial outcomes. We will use t tests and chi-square tests to assess baseline differences and repeated-measures ANCOVA to assess changes over time.

Results

Participant recruitment started in March 2025, and we expect to recruit until late 2026. We will begin analyzing baseline data in 2026.

Conclusions

Successful study completion will provide valuable insights into the remote delivery of PA-oriented supportive care for cancer survivors experiencing chemo-brain, as well as how T2DM and PA contribute to the mechanistic underpinnings of chemo-brain. Trial Registration ClinicalTrials.gov NCT06725953; https://clinicaltrials.gov/study/NCT06725953 International Registered Report Identifier (IRRID) DERR1-10.2196/79739

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cancer SurvivorsExerciseSmartphoneChemotherapy-Related Cognitive ImpairmentNeoplasmsHumansPilot ProjectsQuality of LifeFemaleMaleMiddle AgedAged

Stichwörter der Autor:innen

aerobic physical activityresistance trainingsmartphone applicationssocial cognitive theorywearable technology

Autor:innen und Institutionen

  • TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Health Promotion Sciences, Hudson College of Public Health, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Neurosurgery, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Pediatrics, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Harold Hamm Diabetes Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States.

ORCID-Profile: Zachary C Pope, Andriy Yabluchanskiy, Peter Mukli, Michael C Robertson, Jason A Oliver, Sarah J Borengasser, Meghan M Ratke, Jacob E Matney, Chris Mixon, Christina Henson, J Mikhail Kellawan

Zitieren

APA

Pope, Z. C., Yabluchanskiy, A., Mukli, P., Robertson, M. C., Oliver, J. A., Borengasser, S. J., Ratke, M. M., Matney, J. E., Mixon, C., Henson, C., & Kellawan, J. M. (2025). Smartphone-Based Physical Activity Program to Reduce “Chemo-Brain” Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial. JMIR Research Protocols. https://doi.org/10.2196/79739

Vancouver

Pope ZC, Yabluchanskiy A, Mukli P, Robertson MC, Oliver JA, Borengasser SJ, et al. Smartphone-Based Physical Activity Program to Reduce “Chemo-Brain” Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial. JMIR Research Protocols. 2025. doi:10.2196/79739

BibTeX
@article{Pope2025,
  author = {Pope, Zachary C and Yabluchanskiy, Andriy and Mukli, Peter and Robertson, Michael C and Oliver, Jason A and Borengasser, Sarah J and Ratke, Meghan M and Matney, Jacob E and Mixon, Chris and Henson, Christina and Kellawan, J Mikhail},
  title = {Smartphone-Based Physical Activity Program to Reduce “Chemo-Brain” Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/79739}
}
Kostenlos starten →